Dr Sam Asgarian - Guardant Health - Shield CRC Cancer Screening

Sam Asgarian, MD, Vice President, Clinical Development, Guardant Health talks with Bruce Newbury. Guardant Health, a leader in precision oncology, recently launched Shield, the first FDA-approved blood test for primary colorectal cancer (CRC) screening. Rhode Island is one of the first states in the nation to receive it. As broadcast WADK AM/FM Newport RI.